PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

被引:209
作者
Naing, Aung [1 ]
Infante, Jeffrey R. [2 ]
Papadopoulos, Kyriakos P. [3 ]
Chan, Ivan H. [4 ]
Shen, Cong [5 ]
Ratti, Navneet P. [4 ]
Rojo, Bianca [4 ]
Autio, Karen A. [5 ]
Wong, Deborah J. [6 ]
Patel, Manish R. [7 ]
Ott, Patrick A. [8 ]
Falchook, Gerald S. [9 ]
Pant, Shubham [10 ]
Hung, Annie [4 ]
Pekarek, Kara L. [4 ]
Wu, Victoria [4 ]
Adamow, Matthew [5 ]
McCauley, Scott [4 ]
Mumm, John B. [4 ]
Wong, Phillip [5 ]
Van Vlasselaer, Peter [4 ]
Leveque, Joseph [4 ]
Tannir, Nizar M. [1 ]
Oft, Martin [4 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] PLLC, Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[3] START Ctr Canc Care, San Antonio, TX USA
[4] Eli Lilly & Co, ARMO BioSci, Redwood City, CA 94063 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Sarah Cannon Res Inst Florida Canc Specialists, Sarasota, FL USA
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Sarah Cannon Res Inst HealthONE, Denver, CO USA
[10] Univ Oklahoma, Oklahoma City, OK USA
关键词
EFFECTOR FUNCTION; PD-1; BLOCKADE; TUMOR; INTERLEUKIN-10; SPECIFICITY; RECEPTORS; TOLERANCE; RESPONSES; MELANOMA; DEATH;
D O I
10.1016/j.ccell.2018.10.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Tumor-reactive T cell exhaustion prevents the success of immune therapies. Pegilodecakin activates intratumoral CD8(+ )T cells in mice and induces objective tumor responses in patients. Here we report that pegilodecakin induces hallmarks of CD8(+ ) T cell immunity in cancer patients, including elevation of interferon-y and GranzymeB, expansion and activation of intratumoral CD8(+ ) T cells, and proliferation and expansion of LAG-3(+) PD-1(+) CD8(+ ) T cells. On pegilodecakin, newly expanded T cell clones, undetectable at baseline, become 1 %-10% of the total T cell repertoire in the blood. Elevation of interleukin-18, expansion of LAG-3(+) PD-1(+) T cells and novel T cell clones each correlated with objective tumor responses. Combined pegilodecakin with anti-PD-1 increased the expansion of LAG-3(+) PD-1(+) CD8(+ ) T cells.
引用
收藏
页码:775 / +
页数:20
相关论文
共 47 条
[1]
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers [J].
Afanasiev, Olga K. ;
Yelistratova, Lola ;
Miller, Natalie ;
Nagase, Kotaro ;
Paulson, Kelly ;
Iyer, Jayasri G. ;
Ibrani, Dafina ;
Koelle, David M. ;
Nghiem, Paul .
CLINICAL CANCER RESEARCH, 2013, 19 (19) :5351-5360
[2]
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation [J].
Anderson, Ana C. ;
Joller, Nicole ;
Kuchroo, Vijay K. .
IMMUNITY, 2016, 44 (05) :989-1004
[3]
[Anonymous], 2011, TRENDS IMMUNOL, DOI DOI 10.1016/J.IT.2011.01.003
[4]
Consensus nomenclature for CD8+ T cell phenotypes in cancer [J].
Apetoh, Lionel ;
Smyth, Mark J. ;
Drake, Charles G. ;
Abastado, Jean-Pierre ;
Apte, Ron N. ;
Ayyoub, Maha ;
Blay, Jean-Yves ;
Bonneville, Marc ;
Butterfield, Lisa H. ;
Caignard, Anne ;
Castelli, Chiara ;
Cavallo, Federica ;
Celis, Esteban ;
Chen, Lieping ;
Colombo, Mario P. ;
Comin-Anduix, Begona ;
Coukos, Georges ;
Dhodapkar, Madhav V. ;
Dranoff, Glenn ;
Frazer, Ian H. ;
Fridman, Wolf-Herve ;
Gabrilovich, Dmitry I. ;
Gilboa, Eli ;
Gnjatic, Sacha ;
Jaeger, Dirk ;
Kalinski, Pawel ;
Kaufman, Howard L. ;
Kiessling, Rolf ;
Kirkwood, John ;
Knuth, Alexander ;
Liblau, Roland ;
Lotze, Michael T. ;
Lugli, Enrico ;
Marincola, Francesco ;
Melero, Ignacio ;
Melief, Cornelis J. ;
Mempel, Thorsten R. ;
Mittendorf, Elizabeth A. ;
Odun, Kunle ;
Overwijk, Willem W. ;
Palucka, Anna Karolina ;
Parmiani, Giorgio ;
Ribas, Antoni ;
Romero, Pedro ;
Schreiber, Robert D. ;
Schuler, Gerold ;
Srivastava, Pramod K. ;
Tartour, Eric ;
Valmori, Danila ;
van der Burg, Sjoerd H. .
ONCOIMMUNOLOGY, 2015, 4 (04)
[5]
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[6]
The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[7]
CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors [J].
Chmielewski, Markus ;
Abken, Hinrich .
CELL REPORTS, 2017, 21 (11) :3205-3219
[8]
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes [J].
Cohen, Cyrille J. ;
Gartner, Jared J. ;
Horovitz-Fried, Miryam ;
Shamalov, Katerina ;
Trebska-McGowan, Kasia ;
Bliskovsky, Valery V. ;
Parkhurst, Maria R. ;
Ankri, Chen ;
Prickett, Todd. D. ;
Crystal, Jessica S. ;
Li, Yong F. ;
El-Gamil, Mona ;
Rosenberg, Steven A. ;
Robbins, Paul F. .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (10) :3981-3991
[9]
An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells [J].
Cui, Weiguo ;
Liu, Ying ;
Weinstein, Jason S. ;
Craft, Joseph ;
Kaech, Susan M. .
IMMUNITY, 2011, 35 (05) :792-805
[10]
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma [J].
Daud, Adil I. ;
Loo, Kimberly ;
Pauli, Mariela L. ;
Sanchez-Rodriguez, Robert ;
Sandoval, Priscila Munoz ;
Taravati, Keyon ;
Tsai, Katy ;
Nosrati, Adi ;
Nardo, Lorenzo ;
Alvarado, Michael D. ;
Algazi, Alain P. ;
Pampaloni, Miguel H. ;
Lobach, Iryna V. ;
Hwang, Jimmy ;
Pierce, Robert H. ;
Gratz, Iris K. ;
Krummel, Matthew F. ;
Rosenblum, Michael D. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09) :3447-3452